Physician
Boro Park Pediatric Associates, PLLC
Boro Park Pediatric Associates, PLLC was paid $31.12M by Medicaid between Jan 2018 and Jan 2023, across 63 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoBORO PARK PEDIATRIC ASSOCIATES, PLLC
BROOKLYN, NY 11219
BROOKLYN, NY 11219
33aNPI1063629186assigned 05/17/2007
33bProvider typePediatrics Physician
28Total paid$31.12M
24GClaims873,841
24DCodes billed63
24AFirst – last monthJan 2018 – Jan 2023
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#2 of 1,983
Median peer was paid$17K
This provider vs. median1,834×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 137,808 | $5.23M | |
| 2019 | 176,884 | $5.02M | |
| 2020 | 162,682 | $5.40M | |
| 2021 | 193,954 | $7.19M | |
| 2022 | 196,454 | $8.03M | |
| 2023 | 6,059 | $246K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 223,138 | 195,871 | $17.31M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.2% | 22,281 | 22,263 | $2.24M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.7% | 17,809 | 17,803 | $1.77M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.9% | 48,906 | 48,697 | $1.52M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.6% | 15,977 | 15,783 | $1.44M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 9,361 | 9,361 | $957K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.6% | 6,416 | 6,243 | $805K |
| 87070 | 2.6% | 99,254 | 93,253 | $796K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.2% | 14,804 | 14,600 | $677K |
| 87184 | 2.1% | 99,446 | 93,432 | $647K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 98,366 | 92,760 | $588K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 18,543 | 17,902 | $562K |
51 more codes
| 99050 | 1.6% | 46,356 | $513K | |
| 69210 | 1.1% | 6,721 | $345K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 54,347 | $217K |
| 83655 | <1% | 7,899 | $112K | |
| 99460 | <1% | 1,721 | $105K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 1,836 | $102K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 1,549 | $71K |
| 97803 | <1% | 9,666 | $66K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 604 | $61K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 6,788 | $57K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,515 | $27K |
| 99381 | <1% | 242 | $26K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 504 | $24K |
| 90461 | <1% | 1,811 | $21K | |
| 99383 | <1% | 106 | $9K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 409 | $8K |
| 81003 | <1% | 3,928 | $7K | |
| 99462 | <1% | 187 | $5K | |
| 98926 | <1% | 105 | $5K | |
| 94664 | <1% | 273 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 24 | $3K |
| 99382 | <1% | 30 | $3K | |
| 99384 | <1% | 26 | $3K | |
| 36416 | <1% | 38,216 | $2K | |
| 51701 | <1% | 70 | $2K | |
| 90686 | <1% | 3,511 | $2K | |
| 12001 | <1% | 13 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 13 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 108 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 18 | $1K |
| 99234 | <1% | 13 | $1K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 15 | $1K |
| 99221 | <1% | 12 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 481 | $395.55 |
| 90715 | <1% | 66 | $207.66 | |
| 94760 | <1% | 91 | $161.79 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 102 | $122.42 |
| 90633 | <1% | 529 | $30.00 | |
| 99173 | <1% | 48 | $20.00 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 47 | $18.90 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 101 | $12.42 |
| 90697 | <1% | 653 | $10.25 | |
| 90723 | 0% | 1,563 | $0.00 | |
| 90647 | 0% | 1,352 | $0.00 | |
| 90696 | 0% | 231 | $0.00 | |
| 99000 | 0% | 45 | $0.00 | |
| 90710 | 0% | 547 | $0.00 | |
| 90670 | 0% | 2,573 | $0.00 | |
| 90707 | 0% | 72 | $0.00 | |
| 90700 | 0% | 111 | $0.00 | |
| 90734 | 0% | 292 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDIAMOND, DAVID (CEO)